IU researchers and their collaborators studied how using near-infrared spectroscopy to track tissue oxygen levels during heart surgery affected patients afterward.

Researchers have discovered a new pathway toward treating acute myeloid leukemia, an aggressive blood cancer in adults. 

Dean Jay L. Hess, who led the Indiana University School of Medicine to new heights in his decade-long tenure, will leave leadership roles.  

A new research paper explores how AI, other advanced technologies are being used to diagnose and treat cancer. 

A new treatment for neurobehavioral symptoms caused by neurofibromatosis type 1, or NF1, has shown promise. 

IU School of Medicine scientists have discovered a potential new strategy to combat leukemia through a special approach that targets both cancer cells and their ...

IU School of Medicine researchers aim to develop a new treatment for neurodegeneration by targeting an immune cell-specific gene associated with Alzheimer's disease.

IU School of Medicine researchers have identified a portfolio of novel drug targets that may accelerate promising treatments for people living with Alzheimer’s disease.

The Accreditation Council for Graduate Medical Education approved new emergency and internal medicine residency programs in Bloomington. 

A new clinical trial, the first of its kind, showed positive outcomes for certain Type 1 diabetes patients when taking semaglutide once per week.